# Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat

> **NCT02035267** · PHASE3 · COMPLETED · sponsor: **Kythera Biopharmaceuticals** · enrollment: 93 (actual)

## Conditions studied

- Moderate to Severe Convexity of Submental Fat
- Safety
- Efficacy

## Interventions

- **DRUG:** Deoxycholic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02035267
- **Lead sponsor:** Kythera Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02035267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02035267, "Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT02035267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*